You are here: Industry Insights > BIVF

News List

Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies prnasia
June 18, 2021
Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion of an oversubscribed $24 million Series A financing round.
Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of its Innovative Synthetic Vaccines prnasia
March 12, 2021
Delonix Bioworks Ltd., a biotechnology company dedicated to developing the next generation vaccines with synthetic biology approaches, has recently closed a $14 million Series Seed financing led by Boehringer Ingelheim Venture Fund (BIVF) and IDG ...
Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic b3cnewswire
September 27, 2019
T3 Pharmaceuticals AG (T3), a Basel (Switzerland)-based company focusing on immuno-oncology, closes its second financing round of over 12M CHF with existing investors joined by ...